QA: Globestar Therapeutics Corp in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001502152_2016_Globestar_Therapeutics_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001502152, Globestar Therapeutics Corp

  xvar xval
0 AssetsCurrent 11,180
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 311,133
4 LiabilitiesCurrent 246,830
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 62,842
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 883,857
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 52,047
11 remainder_Revenues 23,996
12 remainder_NetIncome -678,961
13 remainder_ComprehensiveNetIncome 3,900
  yvar yval
0 Assets 322,313
1 Liabilities 309,672
2 Expenses 935,904
3 Revenues 23,996
4 StockholdersEquity 12,641
5 NetIncome -1,590,869
6 ComprehensiveNetIncome -1,588,919
7 BaseVar 1,137,373
8 EconomicCapitalRatiobeforeLimitedLiability -4.94
9 EconomicCapitalRatio 0.200

Edgar->Model Mapping

Feature Distribution

Change over Time